| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.1 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.1 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.081 | 0.1 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.058 | 0.1 |